Navigating the Pharma Data Revolution with AstraZeneca

How to accelerate research to support the generation of improved patient outcomes

Join our exclusive webinar with NTT DATA and AstraZeneca Japan healthcare technology executives for an expert discussion on RWE in commercial and medical fields, and the challenges — and benefits — of implementing effective patient and clinical big data analytics.

COVID-19 changed the world. The response to it transformed healthcare.

The pandemic put drug discovery and clinical trials in the public spotlight more than ever before. Real-world evidence (RWE) and clinical data became priceless commodities in the research and development of vaccines and medications to combat the global threat of coronavirus.

More recently, global regulators have incentivized real-world data (RWD) in clinical trials to improve healthcare and patient outcomes, from research directions and pharmaceutical efficacy to medication adherence and medical cost. At the same time, changing disease profiles and patient expectations have made secure, personalized digital healthcare experiences essential.

In a post-pandemic world, how can we effectively scale RWD to size the market, drive product strategy and create greater value for patients and medical professionals?

Pharmaceutical, medical product and life sciences companies can achieve a distinct competitive advantage by integrating RWD into R&D to shorten the discovery cycle, improve population health outcomes and customize patient care. With the rise of Generative AI, we see the potential to automate and curate, accelerating research processes and insight generation.

However, processing large volumes of unstructured RWD with surgical precision presents technical and organizational challenges in an endlessly growing data ecosystem.

Streamlining, harmonizing and analyzing data from multiple sources increases the risk of inaccurate or unintentionally biased information. Compared to legacy systems, collecting patient data in real-time from remote channels such as wearables puts greater pressure on consumer privacy and protection.

Join Phil Rust (Lead Enterprise Architect, Healthcare, NTT DATA UK&I) and Harsh Gandhi (Chief Information and Digital Officer AstraZeneca K.K.) on an exclusive webinar to learn how cutting-edge technologies can address these challenges and deliver better business and patient outcomes.

From improved cohort selection and data security to optimal sales and marketing efforts, the expert session will tackle the key technical, operational and strategic benefits of RWE implementation and process optimization, the role of system integrators, and future trends for both technology and industry.